A Novel Minimally Invasive Surgical Technique for Treating Non-Traumatic Adhesive Syringomyelia Associated with a History of Previous Spinal Canal Surgical Interventions

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Purpose Current surgical options for treating nontraumatic adhesive syringomyelia, particularly in patients with a history of previous spinal canal surgical intervention (PSCAS), lack clear standardization and frequently lead to common complications such as recurrent adhesions, tube disconnections, and neurological injuries related to myelotomy, resulting in the need for multiple revision surgeries. This study aims to introduce a novel, minimally invasive technique of modified subarachnoid-subarachnoid (S−S) bypass procedure for PSCAS and to prospectively evaluate its surgical outcomes. Methods This prospective study included 11 consecutive non-traumatic patients with symptomatic PSCAS who underwent modified S-S bypass surgery, with a mean follow-up period of 18.3 months (range: 16-20 months). Neurological function was assessed using standardized grading systems, and changes in syrinx size were evaluated using MRI. Results Ten patients demonstrated clinical improvement, while one patient remained stable. Notably, the preoperative and postoperative ASIA motor and sensory scores showed significant improvement (88.45 ± 11.01 vs. 89.64 ± 9.99, p < 0.05; 200.73 ± 15.52 vs. 203.09 ± 15.29, p < 0.001). The mean syrinx tension index postoperatively was significantly lower than the preoperative value (74.28 ± 14.34% vs. 29.87 ± 17.62%, p < 0.0001), and the syrinx length was also significantly reduced (9.46 ± 4.59 vs. 8.00 ± 6.05, p < 0.05). Conclusions This study highlights that the modified S-S bypass can be performed without myelotomy or intratubal interaction with CSF circulation, representing not only a safe and effective surgical technique but also a potentially more physiological approach for treating PSCAS.

Article activity feed